April 14, 2021 | Published on Forbes
bit.bio Co-founder and CFO Florian Schuster, investor and Lyell founder, Rick Klausner, and bit.bio founder and CEO Mark Kotter
John Cumbers, founder and CEO of SynBioBeta, published a piece in Forbes after a conversation with Dr Rick Klausner – bit.bio investor, founder and Executive Chairman of Lyell Immunopharma – and Dr Mark Kotter, bit.bio founder and CEO.
The piece covers how Rick and Mark first met and how bit.bio is reimagining what is possible with the engineering of mammalian cells – industrial-scale cell manufacturing and bringing sustainable cell-culture meats to consumers via Meatable.
bit.bio investor, founder and Executive Chairman of Lyell Immunopharma
CEO and founder, bit.bio